Meet the Team

Dr. Bousman received his Bachelor of Science from the University of Wisconsin-La Crosse, a Master in Public Health from San Diego State University, and a PhD from the University of California-San Diego. Prior to arriving at the University of Calgary, he spent seven years at the University of Melbourne, Department of Psychiatry, where he remains a Honorary Senior Research Fellow. Dr. Bousman is a full member of the Alberta Children's Hospital Research Institute, Hotchkiss Brain Institute, and Mathison Centre for Mental Health Research and Education. In addition, Dr. Bousman is a member of the Clinical Pharmacogenetics Implementation Consortium, Pharmacogene Variation Consortium, and Pharmacogenomics Research Network.

Dr. Abdullah Al Maruf is a Pharmacist in training and holds a M.Sc. in Clinical Pharmacology and a PhD in Pharmacology and Toxicology. He would like to capitalize on his past education and research training during his Bachelor’s and Master’s of Pharmacy studies in Bangladesh that focused on genetic epidemiological studies in diseased and healthy population and epidemiological assessment of health hazards in vulnerable communities and his doctoral work at the University of Toronto that focused on idiosyncratic drug-induced liver injury.

Dr. Ankita is a Genome Bioinformatician by training. She is deeply interested in understanding the nature and context of genomic variants in populations and diseases. During her PhD, she focused her research on understanding the genetic architecture of Afro-Indian admixed population. During her Postdoctoral work at University of Delhi, she integrated different OMICs data to find molecular players of sexual dimorphism and sex specific heterochromatisation in mealybugs (insect species). Her research also involved the analysis of clinical whole genome/exome sequencing data to delineate novel mutations in genetically rare diseases. In the Psychiatric Pharmacogenetics Lab, she will apply her experience and expertise to uncover genetic markers for clozapine-induced myocarditis as well as integrate population genomics methods/frameworks with pharmacogenetics data to aid in ancestry specific dosing recommendation of clinically actionable variants.

Diogo received his Bachelor of Biomedical Sciences from the Federal University of Sao Paulo - Medical School of Sao Paulo (UNIFESP-EPM) in Brazil, where he completed a Genetics specialization. Then, he completed a Master’s degree in the Psychiatry and Medical Psychology Program at the same University studying how risperidone (antipsychotic) effects DNA methylation in repetitive regions as the retrotransposon LINE-1. As a Ph.D. student in the PsychPGx Lab, Diogo will be conducting pharmacoepigenetic analyses related to clozapine-induced myocarditis using patient-derived cardiomyocytes.

Nazanin completed her Master's degree in Biotechnology from the University of Greenwich in England. She has conducted research on the cellular mechanism of breast cancer. Nazanin will continue to pursue her passion for uncovering the cellular mechanisms of disease and will be working on the PROCLAIM study. Her PhD will investigate the mechanism underlying the cardiac toxicity of clozapine and potential pharmacological modulators of this toxicity using unique patient-derived induced pluripotent stem cells..

Dr. Toyin Shonubi is an international medical graduate who holds a Bachelor of Medicine and Surgery from Nigeria with clinical and research experience in mental health. She is passionate about mental health and will leverage her past research training during her residency program in Nigeria that focused on severe depression and suicide. She will be assisting with recruitment efforts across the range of projects being conducted within the PsychPGx Lab. She also hopes to pursue her medical practice in Canada.

Mikayla is a Biomedical Sciences student and Chancellor’s Club Scholar at the University of Calgary. She has previously interned within the Wasserman Lab at BC Children's Hospital Research Institute, which does exome and genome analysis for rare paediatric diseases. Mikayla would like to pursue her passion for genetics by continuing to gain research experience within this field. To this end, she has received a Program for Undergraduate Research Experience (PURE) award to conduct a systematic evaluation of commercial pharmacogenetic tests ability to facilitate the implementation of international dosing guidelines.

Noah Richardson is a Biomedical Sciences student at the University of Calgary. While he is hoping to pursue a career in medicine, he is active on campus in both sciences as well as the arts, appearing in performances with the student run theatre at the University. Noah is hoping to explore pharmacogenetics in order to extend his understanding of how genetics interface with medicine. Noah will be working on the PROCLAIM study this year to gain research experience and continue expanding his passion in both genetics and medicine.

Aisouda is a Neuroscience student at the University of Calgary. She is the Vice President of Marketing for the Neuroscience Student Association. She has conducted research on the influence of Ibuprofen in water bodies on neuronal regeneration in Lymnaea stagnalis. Additionally, Aisouda has finished a summer studentship at the Ungrin lab working on Age-Related Macular Degeneration treatments. Aisouda’s passion for mental health research and improving current therapeutic methods has made her interested in the field of pharmacogenetics. Her research will focus on the CYP450 enzymatic family and how it relates to brain function and structure as well as behaviour.

Chaten is a first year Neuroscience Student at the University of Calgary. This past year he served as a First-Year representative on the Neuroscience Students Association, and also volunteered as a VP External for Run for the Little Ones, a non-profit student-run organization that raises money for the Neuro-critical Care Unit at the Alberta Children's Hospital. This is Chaten’s first experience doing research and he’s super excited to explore the field of antidepressant pharmacogenetics.